Quarterly report pursuant to Section 13 or 15(d)

Document and Entity Information

Document and Entity Information - shares
3 Months Ended
Dec. 31, 2019
Mar. 25, 2020
Document and Entity Information    
Entity Registrant Name NEUBASE THERAPEUTICS, INC.  
Entity Central Index Key 0001173281  
Document Type 10-Q  
Trading Symbol NBSE  
Document Period End Date Dec. 31, 2019  
Amendment Flag false  
Current Fiscal Year End Date --09-30  
Entity's Reporting Status Current Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Shell Company false  
Entity Emerging Growth Company false  
Entity Common Stock, Shares Outstanding   17,080,625
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2020  
Entity File Number 333-88480  
Entity Incorporation, State Code DE